Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

142 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A predictive mortality score in ANCA-associated renal vasculitis.
Fage N, Quéméneur T, Riou J, Boud'hors C, Desouche A, Vinatier E, Samoreau C, Coindre JP, Djema A, Henry N, Gnemmi V, Copin MC, Piccoli GB, Vandenbussche C, Augusto JF, Brilland B; Maine-Anjou Registry Research Group. Fage N, et al. Among authors: vandenbussche c. Nephrol Dial Transplant. 2024 Aug 30;39(9):1461-1472. doi: 10.1093/ndt/gfae035. Nephrol Dial Transplant. 2024. PMID: 38327221
Tubulointerstitial damage and interstitial immune cell phenotypes are useful predictors for renal survival and relapse in antineutrophil cytoplasmic antibody-associated vasculitis.
Bitton L, Vandenbussche C, Wayolle N, Gibier JB, Cordonnier C, Verine J, Humez S, Bataille P, Lenain R, Ramdane N, Azar R, Mac Namara E, Hatron PY, Maurage CA, Perrais M, Frimat M, Vanhille P, Glowacki F, Buob D, Copin MC, Quéméneur T, Gnemmi V. Bitton L, et al. Among authors: vandenbussche c. J Nephrol. 2020 Aug;33(4):771-781. doi: 10.1007/s40620-019-00695-y. Epub 2020 Jan 8. J Nephrol. 2020. PMID: 31916228
Reappraisal of Renal Arteritis in ANCA-associated Vasculitis: Clinical Characteristics, Pathology, and Outcome.
Boudhabhay I, Delestre F, Coutance G, Gnemmi V, Quemeneur T, Vandenbussche C, Lazareth H, Canaud G, Tricot L, Gosset C, Hummel A, Terrier B, Rabant M, van Daalen EE, Wester Trejo MAC, Bajema IM, Karras A, Duong Van Huyen JP. Boudhabhay I, et al. Among authors: vandenbussche c. J Am Soc Nephrol. 2021 Sep;32(9):2362-2374. doi: 10.1681/ASN.2020071074. Epub 2021 Jun 21. J Am Soc Nephrol. 2021. PMID: 34155059 Free PMC article.
Early Renal Recovery after the First Flare of Pauci-Immune Glomerulonephritis.
Zaworski J, Gnemmi V, Bataille P, Hachulla E, Glowacki F, Gibier JB, Daroux M, Ratsimbazafy A, Bitton L, Humez S, Guincestre T, Béhal H, Azar R, Hoffmann M, Cardon G, Bourdon F, Lemoine C, Auxenfant E, Copin MC, Vandenbussche C, Quéméneur T; pour la cohorte RENVAS. Zaworski J, et al. Among authors: vandenbussche c. Am J Nephrol. 2022;53(1):59-68. doi: 10.1159/000520285. Epub 2022 Jan 17. Am J Nephrol. 2022. PMID: 35038711
Tacrolimus-induced nephrotoxicity in mice is associated with microRNA deregulation.
Vandenbussche C, Van der Hauwaert C, Dewaeles E, Franczak J, Hennino MF, Gnemmi V, Savary G, Tavernier Q, Nottet N, Paquet A, Perrais M, Blum D, Mari B, Pottier N, Glowacki F, Cauffiez C. Vandenbussche C, et al. Arch Toxicol. 2018 Apr;92(4):1539-1550. doi: 10.1007/s00204-018-2158-3. Epub 2018 Jan 23. Arch Toxicol. 2018. PMID: 29362864
Tools, techniques, and challenges in preparing cytology specimens for ancillary studies: results of the ASC Optimizing Cytology and Small Biopsy Specimen Processing for Ancillary Studies task force survey.
Heymann JJ, Pineda CM, Booth CN, Jenkins E, Menke JR, Monaco SE, Nayar R, Nishino M, Roy-Chowdhuri S, Ruiz-Cordero R, Russell DK, Saqi A, Sundling KE, Thrall MJ, Torous VF, VandenBussche CJ, VanderLaan PA, Zhang ML, Siddiqui MT. Heymann JJ, et al. Among authors: vandenbussche cj. J Am Soc Cytopathol. 2024 Oct 16:S2213-2945(24)00215-1. doi: 10.1016/j.jasc.2024.10.001. Online ahead of print. J Am Soc Cytopathol. 2024. PMID: 39547835
The immune response to Covid-19 mRNA vaccination among Lymphoma patients receiving anti-CD20 treatment.
Komlodi-Pasztor E, Escarra-Senmarti M, Bazer DA, Bhatnagar A, Perez Heydrich CA, Messmer M, Ambinder RF, Gladstone DE, Clayton L, Goodrich A, Schoch L, Wagner-Johnston N, VandenBussche CJ, Huang P, Holdhoff M, Rosario M. Komlodi-Pasztor E, et al. Among authors: vandenbussche cj. Front Immunol. 2024 Sep 4;15:1433442. doi: 10.3389/fimmu.2024.1433442. eCollection 2024. Front Immunol. 2024. PMID: 39295862 Free PMC article.
142 results